Literature DB >> 20719957

Evaluation of the cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae.

Rebecca Rockett1, Namraj Goire, Athena Limnios, Mark Turra, Geoffrey Higgens, Stephen B Lambert, Cheryl Bletchly, Michael D Nissen, Theo P Sloots, David M Whiley.   

Abstract

OBJECTIVES: To investigate the performance of the fully automated cobas 4800 CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
METHODS: The study was conducted using 900 clinical specimens (496 urine and 404 swab specimens) for C trachomatis testing, of which 498 specimens (318 urine and 180 swab specimens) were also tested for N gonorrhoeae. The results of the cobas 4800 CT/NG test were compared with those obtained from the Roche COBAS AMPLICOR CT/NG and COBAS TaqMan CT assays. N gonorrhoeae-positive specimens were further tested using in-house, real-time PCR assays. A panel of 223 Neisseria isolates was used to further investigate the performance of the cobas 4800 N gonorrhoeae assay.
RESULTS: For urine specimens, the sensitivity, specificity and negative and positive predictive values of the cobas 4800 CT/NG test were 94.5%, 99.5%, 98.8% and 97.7%, respectively, for C trachomatis, and 92.9%, 100%, 99.7% and 100%, respectively, for N gonorrhoeae. For swab specimens, the sensitivity, specificity and negative and positive predictive values were 92.0%, 100%, 99.5% and 100%, respectively, for C trachomatis, and 100%, 99.4%, 100% and 90.0%, respectively, for N gonorrhoeae. All N gonorrhoeae isolates were positive and all non-gonococcal Neisseria strains were negative by the cobas 4800 N gonorrhoeae assay.
CONCLUSIONS: The cobas 4800 CT/NG test is suitable for high through-put identification of C trachomatis and N gonorrhoeae infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719957     DOI: 10.1136/sti.2010.042812

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  16 in total

1.  Supplementary testing is not required in the cobas 4800 CT/NG test for Neisseria gonorrhoeae weak-positive urogenital samples.

Authors:  Collette Bromhead; Nadika Liyanarachchy; Julia Mayes; Arlo Upton; Michelle Balm
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species.

Authors:  Sepehr N Tabrizi; Magnus Unemo; Athena E Limnios; Tiffany R Hogan; Stig-Ove Hjelmevoll; Susanne M Garland; John Tapsall
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

3.  Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections.

Authors:  Sam Ratnam; Dan Jang; Jodi Gilchrist; Marek Smieja; Andre Poirier; Todd Hatchette; Jean-Frederic Flandin; Max Chernesky
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

4.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urogenital and oral specimens using the cobas® 4800, APTIMA Combo 2® TMA, and ProbeTec™ ET SDA assays.

Authors:  Y Kumamoto; T Matsumoto; M Fujisawa; S Arakawa
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-04-11

5.  Neisseria gonorrhoeae false-positive result obtained from a pharyngeal swab by using the Roche cobas 4800 CT/NG assay in New Zealand in 2012.

Authors:  Arlo Upton; Collette Bromhead; David M Whiley
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

6.  Comparison of the cobas 4800 CT/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand.

Authors:  Collette Bromhead; Amanda Miller; Mark Jones; David Whiley
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

7.  Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs.

Authors:  Max Chernesky; Dan Jang; Jodi Gilchrist; Todd Hatchette; André Poirier; Jean-Frederic Flandin; Marek Smieja; Sam Ratnam
Journal:  J Clin Microbiol       Date:  2014-04-02       Impact factor: 5.948

8.  Despite Excellent Test Characteristics of the cobas 4800 CT/NG Assay, Detection of Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Remains Challenging.

Authors:  J M van Niekerk; B M J W van der Veer; C J P A Hoebe; J van de Bovenkamp; C van Herk; I H M van Loo; L B van Alphen; P F G Wolffs
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

9.  Diagnostic efficacy of a real time-PCR assay for Chlamydia trachomatis infection in infertile women in north India.

Authors:  Benu Dhawan; Jyoti Rawre; Arnab Ghosh; Neena Malhotra; Mir Muneer Ahmed; Vishnubhatla Sreenivas; Rama Chaudhry
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

10.  Should screening for Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-men who have sex with men be recommended?

Authors:  Isabel Pérez-Hernández; Rosario Palacios; Carmen González-Doménech; Victoria García; Manuel Márquez; Encarnación Clavijo; Jesús Santos
Journal:  J Int AIDS Soc       Date:  2014-11-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.